Parkinson’s disease

May 26, 2023

What Lies Ahead For Parkinson’s Disease Psychosis Treatment Market?

May 09, 2023

FDA Approves GSK’s Arexvy for RSV; CHMP’s Opinion on Gilead’s Hepcludex® for HDV; FDA Clearance to ProMIS’s IND Application for PMN310; FDA Grants 501K Clearance to Bladder EpiCheck; PharmaTher Submits Fast Track Application for Ketarx to US FDA; Fast Track Designation to Vedanta Biosciences’ VE303

Dec 30, 2022

Need of the Hour: Enhanced Strategies for PD-LID Treatment and Management

Jul 19, 2022

Byondis’s HER2-targeting ADC trastuzumab duocarmazine; AbbVie Migraine Drug Atogepant; Grünenthal Acquires Bayer’s Testosterone Drug Rights; Vertex Acquires ViaCyte; Merck & Orion Announces Collaboration; Verve Starts Trials of Cholesterol Drug; Kyowa Kirin Drops Nourianz follow-up KW-6356; FDA Orphan Drug and Fast Track Designations to CV-01

May 24, 2022

PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboration with Atara; FDA Accepts Biohaven’s Zavegepant; AbbVie Files FDA Approval for ABBV-951; Innoviva to Acquire Entasis; FDA Orphan Drug Designation to XMT-2056; FDA Approves Azacitidine for Juvenile Myelomonocytic Leukemia

May 12, 2022

Abbott’s Alinity m STI Assay; Phillips’ MR 7700 System; HOYA’s MiYOSMART Spectacle Lens; Magneto’s Pulmonary Embolism Treatment; Owen Mumford and Stevanto Group’s Collaboration Deal; Elekta’s Radiosurgery System-Elekta Esprit

Mar 26, 2021

How Will New Discoveries of Deep Brain Stimulation Devices Transform the Pharma Domain?

Feb 26, 2021

Gene and Cell Therapies in CNS Disorders: Miracle Cure? Opportunities Galore!

Dec 04, 2020

Advancements in Neuromodulation

Oct 19, 2020

The Growing Burden Of Neurodegenerative Disorders

Newsletter/Whitepaper